1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kim, A.S.
Kakalis, L.T.
Abdul-Manan, N.
Liu, G.A.
Rosen, M.K.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Nature
NATUAS
0006
0028-0836
404
151
158
10.1038/35010088
10724160
Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein.
2000
10.2210/pdb1ej5/pdb
pdb_00001ej5
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
11603.597
WISKOTT-ALDRICH SYNDROME PROTEIN
1
man
polymer
WASP
no
no
SGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQGGSGGSQSSEG
LVGALMHVMQKRSRAIHSSDEGEDQAG
SGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQGGSGGSQSSEG
LVGALMHVMQKRSRAIHSSDEGEDQAG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PET11A
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-04-05
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
1CEE CONTAINS THE SOLUTION STRUCTURE OF CDC42 IN COMPLEX WITH THE GTPASE BINDING DOMAIN OF WASP
RCSB
Y
RCSB
2000-02-29
REL
The structure was determined using standard 3D and 4D heteronuclear techniques.
structures with the least restraint violations
100
20
3D_13C-separated_NOESY
3D_15N-separated_NOESY
4D_13C-separated_NOESY
4D_13C/15N-separated_NOESY
HNHA
HCCH-TOCSY
75mM
6.5
ambient
298
K
75mM
6.5
ambient
298
K
75mM
6.5
ambient
298
K
75mM
6.5
ambient
298
K
The structures are based on a total of 2713 restraints, 2494 are NOE-derived
distance constraints, 182 dihedral angle restraints, 31 distance restraints
from hydrogen bonds.
simulated annealing, torsion angle dynamics
14
lowest energy
1.6 mM protein U-15N; 25 mM phosphate buffer pH 6.5, 50 mM NaCl, 1 mM EDTA, 2 mM DTT
90% H2O/10% D2O
1.6 mM protein U-15N,13C; 25 mM phosphate buffer pH 6.5, 50 mM NaCl, 1 mM EDTA, 2 mM DTT
90% H2O/10% D2O
1.6 mM protein U-15N, 10% 13C; 25 mM phosphate buffer pH 6.5, 50 mM NaCl, 1 mM EDTA, 2 mM DTT
90% H2O/10% D2O
1.6 mM protein U-15N,13C; 25 mM phosphate buffer pH 6.5, 50 mM NaCl, 1 mM EDTA, 2 mM DTT
100% D2O
Brunger, Nilges
refinement
CNS
0.3
Brunger
refinement
XPLOR
3.851
Delaglio
processing
NMRPipe
1.7
Jonhson, Blevins
data analysis
NMRView
2.1.2
VARIAN
collection
VNMR
6.1b
Nilges
refinement
ARIA
1
600
Varian
INOVA
500
Varian
INOVA
SER
1
n
1
SER
1
A
GLY
2
n
2
GLY
2
A
PHE
3
n
3
PHE
3
A
LYS
4
n
4
LYS
4
A
HIS
5
n
5
HIS
5
A
VAL
6
n
6
VAL
6
A
SER
7
n
7
SER
7
A
HIS
8
n
8
HIS
8
A
VAL
9
n
9
VAL
9
A
GLY
10
n
10
GLY
10
A
TRP
11
n
11
TRP
11
A
ASP
12
n
12
ASP
12
A
PRO
13
n
13
PRO
13
A
GLN
14
n
14
GLN
14
A
ASN
15
n
15
ASN
15
A
GLY
16
n
16
GLY
16
A
PHE
17
n
17
PHE
17
A
ASP
18
n
18
ASP
18
A
VAL
19
n
19
VAL
19
A
ASN
20
n
20
ASN
20
A
ASN
21
n
21
ASN
21
A
LEU
22
n
22
LEU
22
A
ASP
23
n
23
ASP
23
A
PRO
24
n
24
PRO
24
A
ASP
25
n
25
ASP
25
A
LEU
26
n
26
LEU
26
A
ARG
27
n
27
ARG
27
A
SER
28
n
28
SER
28
A
LEU
29
n
29
LEU
29
A
PHE
30
n
30
PHE
30
A
SER
31
n
31
SER
31
A
ARG
32
n
32
ARG
32
A
ALA
33
n
33
ALA
33
A
GLY
34
n
34
GLY
34
A
ILE
35
n
35
ILE
35
A
SER
36
n
36
SER
36
A
GLU
37
n
37
GLU
37
A
ALA
38
n
38
ALA
38
A
GLN
39
n
39
GLN
39
A
LEU
40
n
40
LEU
40
A
THR
41
n
41
THR
41
A
ASP
42
n
42
ASP
42
A
ALA
43
n
43
ALA
43
A
GLU
44
n
44
GLU
44
A
THR
45
n
45
THR
45
A
SER
46
n
46
SER
46
A
LYS
47
n
47
LYS
47
A
LEU
48
n
48
LEU
48
A
ILE
49
n
49
ILE
49
A
TYR
50
n
50
TYR
50
A
ASP
51
n
51
ASP
51
A
PHE
52
n
52
PHE
52
A
ILE
53
n
53
ILE
53
A
GLU
54
n
54
GLU
54
A
ASP
55
n
55
ASP
55
A
GLN
56
n
56
GLN
56
A
GLY
57
n
57
GLY
57
A
GLY
58
n
58
GLY
58
A
LEU
59
n
59
LEU
59
A
GLU
60
n
60
GLU
60
A
ALA
61
n
61
ALA
61
A
VAL
62
n
62
VAL
62
A
ARG
63
n
63
ARG
63
A
GLN
64
n
64
GLN
64
A
GLU
65
n
65
GLU
65
A
MET
66
n
66
MET
66
A
ARG
67
n
67
ARG
67
A
ARG
68
n
68
ARG
68
A
GLN
69
n
69
GLN
69
A
GLY
70
n
70
GLY
70
A
GLY
71
n
71
GLY
71
A
SER
72
n
72
SER
72
A
GLY
73
n
73
GLY
73
A
GLY
74
n
74
GLY
74
A
SER
75
n
75
SER
75
A
GLN
76
n
76
GLN
76
A
SER
77
n
77
SER
77
A
SER
78
n
78
SER
78
A
GLU
79
n
79
GLU
79
A
GLY
80
n
80
GLY
80
A
LEU
81
n
81
LEU
81
A
VAL
82
n
82
VAL
82
A
GLY
83
n
83
GLY
83
A
ALA
84
n
84
ALA
84
A
LEU
85
n
85
LEU
85
A
MET
86
n
86
MET
86
A
HIS
87
n
87
HIS
87
A
VAL
88
n
88
VAL
88
A
MET
89
n
89
MET
89
A
GLN
90
n
90
GLN
90
A
LYS
91
n
91
LYS
91
A
ARG
92
n
92
ARG
92
A
SER
93
n
93
SER
93
A
ARG
94
n
94
ARG
94
A
ALA
95
n
95
ALA
95
A
ILE
96
n
96
ILE
96
A
HIS
97
n
97
HIS
97
A
SER
98
n
98
SER
98
A
SER
99
n
99
SER
99
A
ASP
100
n
100
ASP
100
A
GLU
101
n
101
GLU
101
A
GLY
102
n
102
GLY
102
A
GLU
103
n
103
GLU
103
A
ASP
104
n
104
ASP
104
A
GLN
105
n
105
GLN
105
A
ALA
106
n
106
ALA
106
A
GLY
107
n
107
GLY
107
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
HE
O
ARG
SER
32
77
1.55
1
A
A
H
O
PHE
LEU
17
40
1.56
2
A
A
H
O
PHE
LEU
17
40
1.58
3
A
A
O
H
ASP
ASN
18
21
1.60
4
A
A
H
O
PHE
LEU
17
40
1.56
5
A
A
O
H
ASP
SER
42
46
1.58
7
A
A
O
H
ASP
SER
42
46
1.59
8
A
A
O
H
ASP
SER
42
46
1.56
8
A
A
H
O
PHE
LEU
17
40
1.57
10
A
A
OD1
HE21
ASP
GLN
55
56
1.57
10
A
A
H
O
PHE
LEU
17
40
1.58
10
A
A
O
H
ASP
SER
42
46
1.60
11
A
A
H
O
PHE
LEU
17
40
1.57
11
A
A
O
H
ASP
SER
42
46
1.58
12
A
A
O
H
ASP
SER
42
46
1.56
12
A
A
H
O
PHE
LEU
17
40
1.57
13
A
A
O
H
ASP
SER
42
46
1.57
13
A
A
H
O
PHE
LEU
17
40
1.58
14
A
A
O
H
ASP
SER
42
46
1.57
14
A
A
H
O
PHE
LEU
17
40
1.60
16
A
A
H
O
PHE
LEU
17
40
1.59
16
A
A
O
H
ASP
SER
42
46
1.60
17
A
A
O
H
ASP
ASN
18
21
1.59
18
A
A
H
O
PHE
LEU
17
40
1.55
18
A
A
O
H
ASP
SER
42
46
1.57
20
A
A
O
H
ASP
SER
42
46
1.60
1
A
SER
75
179.23
-36.72
1
A
SER
78
168.88
-40.31
1
A
SER
93
82.10
-41.01
1
A
ARG
94
-151.33
20.69
1
A
HIS
97
-67.72
72.00
1
A
ASP
104
-168.03
104.96
2
A
SER
99
-170.03
95.32
2
A
ASP
100
62.87
-177.24
2
A
GLU
101
-144.41
-43.37
2
A
ASP
104
40.44
95.17
2
A
GLN
105
-46.66
108.41
3
A
SER
72
51.80
176.67
3
A
SER
77
-49.08
162.93
3
A
SER
78
77.85
-57.32
3
A
HIS
97
-67.04
66.81
3
A
SER
99
61.03
-82.85
4
A
SER
7
59.88
176.53
4
A
ASP
18
-117.74
52.81
4
A
SER
77
-68.72
95.88
4
A
SER
78
166.97
-41.80
4
A
SER
99
60.58
123.12
4
A
ASP
100
59.72
98.18
4
A
ASP
104
42.13
95.81
5
A
HIS
5
-115.41
71.84
5
A
HIS
8
79.21
-53.36
5
A
VAL
9
70.23
-63.47
5
A
SER
72
64.09
125.81
5
A
SER
78
175.11
-44.38
5
A
ILE
96
-59.65
102.09
5
A
SER
98
76.53
56.62
5
A
SER
99
-67.74
-173.94
5
A
ASP
104
40.86
-164.71
5
A
GLN
105
69.47
114.71
6
A
SER
7
59.81
176.72
6
A
HIS
8
-166.80
59.72
6
A
SER
72
59.88
-83.22
6
A
SER
77
-68.70
99.92
6
A
SER
78
179.35
-48.25
6
A
HIS
97
-46.24
92.62
6
A
GLU
101
178.86
-36.41
6
A
ASP
104
39.76
38.26
7
A
VAL
9
-163.87
-70.38
7
A
SER
75
-109.03
44.68
7
A
HIS
97
-54.90
88.47
7
A
SER
99
-116.34
74.33
7
A
ASP
100
-155.02
-46.09
7
A
GLN
105
69.49
172.83
8
A
SER
7
66.82
-64.41
8
A
HIS
8
75.47
51.06
8
A
ASP
18
-118.20
53.23
8
A
SER
72
-175.78
-68.23
8
A
SER
75
88.18
-23.80
8
A
SER
78
164.74
-37.11
8
A
SER
98
80.34
-57.29
8
A
SER
99
56.50
171.79
9
A
HIS
8
-140.55
-56.51
9
A
VAL
9
41.18
95.37
9
A
SER
72
68.94
-63.97
9
A
HIS
97
-65.83
78.87
9
A
SER
98
-110.71
-168.61
9
A
ASP
100
66.98
-68.78
10
A
SER
7
48.13
-89.20
10
A
VAL
9
32.18
101.25
10
A
ASP
100
53.02
90.38
11
A
HIS
5
-112.50
71.12
11
A
VAL
9
67.22
-66.01
11
A
SER
72
66.69
146.04
11
A
SER
75
-111.72
50.37
11
A
SER
78
82.97
-48.22
11
A
ASP
100
54.07
179.71
12
A
HIS
8
68.44
114.58
12
A
SER
72
176.68
-71.28
12
A
HIS
97
-52.88
90.71
12
A
SER
99
-146.55
-44.73
12
A
ASP
100
58.43
73.34
12
A
ASP
104
80.36
151.80
13
A
HIS
8
69.72
80.30
13
A
SER
72
-163.45
72.02
13
A
SER
75
-154.50
38.21
13
A
SER
78
88.22
-27.19
13
A
HIS
97
-43.50
102.83
13
A
ASP
100
60.16
178.48
13
A
ASP
104
-168.43
82.36
14
A
SER
7
58.76
176.62
14
A
HIS
8
-174.85
63.48
14
A
SER
75
-94.21
40.23
14
A
HIS
97
-40.21
93.12
14
A
ASP
104
-167.74
54.32
15
A
SER
78
88.33
-22.74
15
A
HIS
97
-48.77
92.33
15
A
ASP
100
60.64
72.81
15
A
ASP
104
39.44
90.53
16
A
HIS
5
-154.30
57.23
16
A
SER
78
87.76
-25.94
16
A
HIS
97
-67.42
66.65
16
A
SER
99
-63.84
-159.59
16
A
GLU
101
-48.70
101.30
16
A
ASP
104
81.39
-61.53
17
A
SER
7
59.19
-177.07
17
A
HIS
8
-150.53
74.13
17
A
SER
72
54.98
105.80
17
A
SER
78
85.59
-40.82
17
A
HIS
97
69.84
-58.79
17
A
SER
98
177.65
80.90
17
A
ASP
100
-153.87
-46.11
17
A
GLN
105
-110.82
-75.54
18
A
SER
7
56.44
-163.20
18
A
HIS
8
-168.21
66.75
18
A
SER
78
169.30
-40.84
18
A
SER
98
177.62
37.59
18
A
ASP
100
60.35
63.75
18
A
GLN
105
-55.89
109.73
19
A
HIS
5
-109.68
55.70
19
A
SER
72
53.42
-178.55
19
A
SER
75
-105.52
49.81
19
A
HIS
97
-56.86
89.69
19
A
SER
99
-162.76
-84.10
19
A
ASP
100
53.87
91.62
19
A
GLU
101
-173.52
67.47
20
A
HIS
5
-162.67
62.18
20
A
HIS
8
-109.39
61.17
20
A
ASP
100
59.62
94.18
SOLUTION STRUCTURE OF THE AUTOINHIBITED CONFORMATION OF WASP
1
N
N
A
ASP
23
A
ASP
23
HELX_P
A
ALA
33
A
ALA
33
1
1
11
A
SER
36
A
SER
36
HELX_P
A
THR
41
A
THR
41
1
2
6
A
ASP
42
A
ASP
42
HELX_P
A
GLN
56
A
GLN
56
1
3
15
A
GLY
57
A
GLY
57
HELX_P
A
GLN
69
A
GLN
69
1
4
13
A
GLY
80
A
GLY
80
HELX_P
A
MET
89
A
MET
89
1
5
10
A
GLN
90
A
GLN
90
HELX_P
A
SER
93
A
SER
93
5
6
4
BLOOD CLOTTING
alpha helix, beta-hairpin turn, BLOOD CLOTTING
WASP_HUMAN
UNP
1
P42768
242
310
1EJ5
1
69
P42768
A
1
1
69
461
492
1EJ5
76
107
P42768
A
1
76
107
1
SEE REMARK 999
GLY
70
1EJ5
A
P42768
UNP
70
1
SEE REMARK 999
GLY
71
1EJ5
A
P42768
UNP
71
1
SEE REMARK 999
SER
72
1EJ5
A
P42768
UNP
72
1
SEE REMARK 999
GLY
73
1EJ5
A
P42768
UNP
73
1
SEE REMARK 999
GLY
74
1EJ5
A
P42768
UNP
74
1
SEE REMARK 999
SER
75
1EJ5
A
P42768
UNP
75
1
P 1